Meng Sun Selected Research

tyloxapol

12/2021	Structural simplification and bioisostere principle lead to Bis-benzodioxole-fibrate derivatives as potential hypolipidemic and hepatoprotective agents.
1/2021	The combination of sesamol and clofibric acid moieties leads to a novel potent hypolipidemic agent with antioxidant, anti-inflammatory and hepatoprotective activity.
1/2021	1,3-Benzodioxole-based fibrate derivatives as potential hypolipidemic and hepatoprotective agents.
1/2020	3,4-Dihydroxyphenethyl nitrate with nitric oxide releasing, antioxidant, hypoglycemic and hypolipidemic effects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Meng Sun Research Topics

Disease

36	Neoplasms (Cancer) 05/2022 - 01/2007
16	Inflammation (Inflammations) 04/2022 - 04/2011
7	Coronary Artery Disease (Coronary Atherosclerosis) 12/2020 - 01/2015
7	Prostatic Neoplasms (Prostate Cancer) 01/2012 - 01/2008
6	Neoplasm Metastasis (Metastasis) 10/2022 - 07/2011
5	Sepsis (Septicemia) 01/2022 - 10/2016
5	ST Elevation Myocardial Infarction 01/2021 - 06/2017
5	Atherosclerosis 01/2021 - 09/2017
4	Hyperlipidemias (Hyperlipidemia) 12/2021 - 01/2020
4	Infections 01/2021 - 01/2018
4	Rheumatoid Arthritis 01/2021 - 04/2016
4	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2018
3	Stomach Neoplasms (Stomach Cancer) 05/2022 - 01/2019
3	Acute Coronary Syndrome 09/2020 - 07/2008
3	Diabetes Mellitus 01/2020 - 01/2015
3	Leukemia 05/2018 - 01/2007
3	Pancreatic Neoplasms (Pancreatic Cancer) 12/2017 - 11/2014
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2017 - 01/2015
2	Wounds and Injuries (Trauma) 04/2022 - 01/2019
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2021
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2022 - 01/2021
2	Triple Negative Breast Neoplasms 10/2021 - 01/2020
2	Liver Neoplasms (Liver Cancer) 02/2021 - 12/2017
2	Hyperhomocysteinemia 01/2021 - 01/2020
2	Rupture 01/2021 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 11/2017
2	Myocardial Ischemia (Ischemic Heart Diseases) 01/2021 - 12/2018
2	Atherosclerotic Plaque (Atheroma) 01/2021 - 08/2018
2	Hemorrhage 01/2021 - 01/2021
2	COVID-19 01/2021 - 01/2021
2	Primary Graft Dysfunction 03/2020 - 03/2019
2	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020 - 01/2015
2	Reperfusion Injury 03/2019 - 12/2018
2	Dementia (Dementias) 10/2018 - 01/2018
2	Carcinogenesis 12/2017 - 01/2012
2	Ovarian Epithelial Carcinoma 04/2012 - 07/2011

Drug/Important Bio-Agent (IBA)

12	Pharmaceutical PreparationsIBA 04/2022 - 01/2007
10	Biomarkers (Surrogate Marker)IBA 04/2022 - 07/2011
7	MicroRNAs (MicroRNA)IBA 04/2022 - 01/2016
7	Proteins (Proteins, Gene)FDA Link 12/2019 - 01/2015
6	CholesterolIBA 12/2021 - 09/2017
5	Peptides (Polypeptides)IBA 03/2022 - 06/2012
5	LipidsIBA 12/2021 - 12/2016
5	AntioxidantsIBA 01/2021 - 01/2015
5	Histones (Histone)IBA 01/2021 - 08/2018
4	CytokinesIBA 04/2022 - 01/2017
4	tyloxapol FDA Link 12/2021 - 01/2020
4	Biological ProductsIBA 01/2021 - 03/2015
4	AndrogensIBA 02/2011 - 01/2008
4	Androgen Receptors (Androgen Receptor)IBA 02/2011 - 01/2008
3	HydrogelsIBA 04/2022 - 01/2022
3	Antineoplastic Agents (Antineoplastics)IBA 03/2022 - 03/2010
3	CeramidesIBA 01/2021 - 01/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2020 - 01/2007
3	Caspase 3 (Caspase-3)IBA 07/2020 - 01/2015
2	6-methyladenineIBA 10/2022 - 09/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2022 - 03/2010
2	Gemcitabine FDA Link 03/2022 - 12/2017
2	Inosine Triphosphate (ITP)IBA 01/2022 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2022 - 11/2017
2	Triglycerides (Triacylglycerol)IBA 12/2021 - 01/2020
2	Fenofibrate (CiL)FDA LinkGeneric 12/2021 - 01/2021
2	Ethanol (Ethyl Alcohol)IBA 10/2021 - 05/2017
2	Circular RNAIBA 01/2021 - 01/2020
2	EpitopesIBA 01/2021 - 06/2012
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 01/2018
2	Nucleic AcidsIBA 01/2021 - 01/2021
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 08/2010
2	LigandsIBA 11/2020 - 01/2020
2	Small Interfering RNA (siRNA)IBA 11/2020 - 04/2011
2	Sulfhydryl Compounds (Thiols)IBA 07/2020 - 03/2015
2	Prostaglandins DIBA 03/2020 - 03/2019
2	LipopolysaccharidesIBA 01/2020 - 01/2017
2	Phosphotransferases (Kinase)IBA 01/2020 - 08/2010
2	ChemokinesIBA 12/2019 - 04/2016
2	acetyl 4-aminosalicylic acidIBA 12/2019 - 04/2016
2	AntibodiesIBA 12/2019 - 04/2016
2	Long Noncoding RNAIBA 11/2019 - 01/2019
2	trichostatin A (A 300)IBA 01/2015 - 11/2014
2	SurvivinIBA 01/2012 - 03/2010
2	sanguinarineIBA 01/2012 - 03/2010
2	AlkaloidsIBA 01/2012 - 03/2010
2	Interleukin-4 (Interleukin 4)IBA 04/2011 - 01/2008
2	Interleukin-6 (Interleukin 6)IBA 02/2011 - 03/2009
2	multidrug resistance-associated protein 1IBA 02/2007 - 01/2007

Therapy/Procedure

14	Therapeutics 03/2022 - 03/2009
3	Ligation 01/2022 - 10/2016
3	Punctures 01/2022 - 10/2016
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 12/2017
3	Immunotherapy 01/2021 - 06/2012
3	Drug Therapy (Chemotherapy) 07/2020 - 03/2010
3	Castration 02/2011 - 03/2010
2	Lymph Node Excision (Lymph Node Dissection) 02/2022 - 01/2011
2	Radiotherapy 09/2020 - 05/2017
2	Chemoradiotherapy 09/2020 - 01/2011
2	Lung Transplantation 03/2020 - 03/2019
2	Extracorporeal Membrane Oxygenation 03/2019 - 01/2019
2	Percutaneous Coronary Intervention 12/2018 - 06/2017
2	Activities of Daily Living (ADL) 10/2018 - 01/2018